RESOURCES
Company News
Learn about Huateng's latest developments, industry news, and research findings
Exploring effective acute lung injury model: detailed modeling methods
HuaTeng Biotechnology offers rigorously validated Acute Lung Injury (ALI) animal models for ARDS research. Featuring LPS/HCl/mechanical induction, 90% pathological recurrence, and end-to-end services from modeling to cytokine analysis.
Check it out, the most comprehensive disease model for gene-edited pigs is here!
HuaTeng Biotechnology maintains a specialized large-animal gene editing platform, utilizing CRISPR/Cas9, TALEN, and ZFN technologies for precision porcie disease model development.
Are you developing a new medical device, pharmaceutical drug, biologic, or combination product?
We can provide pre - clinical testing services, covering the entire life cycle of the innovation stage and product development.
HT Biotechnology | In Vitro Cell Culture & Analysis Platform
At HuaTeng Biotechnology, our In Vitro Platform empowers researchers with cutting-edge cell-based technologies to streamline drug discovery, biomarker validation, and therapeutic development. From primary cell isolation to advanced gene editing, our GLP-compliant workflows deliver reliable, reproducible data to advance your projects from bench to bedside.
HT Biotechnology | Behavioral Neuroscience & Phenotyping Platform
At HuaTeng Biotechnology, our Behavioral Neuroscience Platform offers comprehensive, standardized testing to evaluate rodent behavior across motor, cognitive, emotional, and social domains. Utilizing validated paradigms and automated tracking systems, we deliver precise, reproducible data for preclinical studies in CNS drug development, neuropsychiatric research, and neurodegenerative disease modeling.
HT Biotechnology | Molecular Biology Testing Platform
At HuaTeng Biotechnology, our Molecular Biology Testing Platform delivers end-to-end solutions for nucleic acid, protein, and biomarker analysis. Leveraging cutting-edge technologies and GLP-compliant workflows, we provide pharmaceutical, biotech, and academic partners with reliable, high-throughput data to advance drug discovery, diagnostic development, and translational research.
HT Biotechnology | Quantitative Analysis Platform
At HuaTeng Biotechnology, our Quantitative Analysis Platform delivers end-to-end solutions for preclinical drug development, combining cutting-edge technologies with GLP-compliant workflows. We provide pharmaceutical, biotech, and academic partners with high-sensitivity, reproducible data to support pharmacokinetic (PK), pharmacodynamic (PD), and toxicology studies, ensuring robust insights from lead optimization to regulatory submissions.
HT Biotechnology | Advanced Histopathology Platform
At HT Biotechnology, our Histopathology Platform offers end-to-end solutions for tissue processing, staining, and advanced imaging. Combining cutting-edge technologies with GLP-compliant workflows, we deliver high-resolution morphological and molecular insights to accelerate drug development, validate medical devices, and advance disease modeling.
HT Biotechnology | Biofluids & Tissue Profiling Platform
At HT Biotechnology, our Biofluids & Tissue Profiling Platform provides comprehensive, GLP-compliant testing services for blood, urine, and tissue samples from experimental animals. Designed for drug developers, medical device innovators, and academic researchers, we deliver reliable, high-throughput data to advance pharmacokinetic studies, toxicity assessments, and disease model validation.
HT Biotechnology | Animal Disease Model Platform for Preclinical Research
At HT Biotechnology, we specialize in designing and validating 200+ standardized and custom animal disease models across species including non-human primates (NHPs), pigs, dogs, rabbits, and rodents. Our platform integrates surgical, chemical, genetic, and dietary induction methods to replicate human disease pathophysiology, enabling precise efficacy and safety evaluations for pharmaceuticals, biologics, and medical devices.
HT Biotechnology | Surgical Platforms for Preclinical Research
At HT Biotechnology, our Advanced Surgical Platforms enable world-class preclinical research through ethically conducted, GLP-compliant animal surgeries. Designed for species ranging from rodents to large animals (pigs, dogs, rabbits, and non-human primates), our facilities and expertise support the creation of robust disease models for drug efficacy evaluation and medical device testing, ensuring your innovations meet global regulatory standards.
HT Biotechnology | Advanced Imaging Platform for Preclinical Research
At HT Biotechnology, our Advanced Imaging Platform integrates cutting-edge technologies to deliver high-resolution, real-time insights into disease mechanisms, therapeutic efficacy, and anatomical dynamics. Designed for preclinical research, our imaging services empower pharmaceutical, biotech, and academic partners to visualize, analyze, and validate discoveries with unmatched clarity and accuracy.
